WallStSmart

Fold Holdings, Inc. Class A Common Stock (FLD)vsMorgan Stanley (MS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Morgan Stanley generates 241413% more annual revenue ($73.17B vs $30.30M). MS leads profitability with a 24.7% profit margin vs -164.6%. MS earns a higher WallStSmart Score of 71/100 (B).

FLD

Hold

38

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.0Quality: 3.3
Piotroski: 3/9Altman Z: -2.33

MS

Strong Buy

71

out of 100

Grade: B

Growth: 9.3Profit: 7.5Value: 4.3Quality: 4.0
Piotroski: 5/9Altman Z: 0.38

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FLD2 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

EPS GrowthGrowth
1622.0%10/10

Earnings expanding 1622.0% YoY

MS5 strengths · Avg: 9.0/10
Market CapQuality
$339.08B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
40.6%10/10

Strong operational efficiency at 40.6%

Profit MarginProfitability
24.7%9/10

Keeps 25 of every $100 in revenue as profit

Revenue GrowthGrowth
16.3%8/10

16.3% revenue growth

EPS GrowthGrowth
31.9%8/10

Earnings expanding 31.9% YoY

Areas to Watch

FLD4 concerns · Avg: 2.5/10
Market CapQuality
$33.11M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-137.2%2/10

ROE of -137.2% — below average capital efficiency

Revenue GrowthGrowth
-21.1%2/10

Revenue declined 21.1%

MS4 concerns · Avg: 1.8/10
PEG RatioValuation
2.542/10

Expensive relative to growth rate

Free Cash FlowQuality
$-7.85B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.382/10

Distress zone — elevated risk

Debt/EquityHealth
3.451/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : FLD

The strongest argument for FLD centers on Price/Book, EPS Growth.

Bull Case : MS

The strongest argument for MS centers on Market Cap, Operating Margin, Profit Margin. Profitability is solid with margins at 24.7% and operating margin at 40.6%. Revenue growth of 16.3% demonstrates continued momentum.

Bear Case : FLD

The primary concerns for FLD are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : MS

The primary concerns for MS are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 3.45 is elevated, increasing financial risk.

Key Dynamics to Monitor

FLD profiles as a turnaround stock while MS is a growth play — different risk/reward profiles.

MS carries more volatility with a beta of 1.21 — expect wider price swings.

MS is growing revenue faster at 16.3% — sustainability is the question.

FLD generates stronger free cash flow (-7M), providing more financial flexibility.

Bottom Line

MS scores higher overall (71/100 vs 38/100), backed by strong 24.7% margins and 16.3% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Fold Holdings, Inc. Class A Common Stock

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Fold Holdings, Inc. (FLD) is an innovative biotechnology company dedicated to advancing therapies for severe genetic and rare diseases through its pioneering research initiatives. With a robust product pipeline fortified by proprietary technologies and strategic collaborations, Fold is well-positioned to capitalize on emerging market opportunities. Its commitment to scientific excellence and patient-focused solutions underscores its potential for sustainable growth and value creation, making FLD an attractive investment prospect in the rapidly evolving healthcare sector.

Visit Website →

Morgan Stanley

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City.

Want to dig deeper into these stocks?